BM
Bill Maughan Canaccord Genuity Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Y-mAbs Therapeutics
YMAB
$390M
| $8.59 | $8.60 |
0%
upside
| Hold |
6 Aug ‘25
1 month ago |
|
2
Krystal Biotech
KRYS
$4.18B
| $144.36 | $190 |
32%
upside
| Buy |
1 Jul ‘25
2 months ago |
|
3
CRISPR Therapeutics
CRSP
$5.08B
| $55.89 | $45 |
19%
downside
| Hold |
27 Jun ‘25
2 months ago |
|
4
Nkarta
NKTX
$147M
| $2.07 | $15 |
625%
upside
| Buy |
10 May ‘24
1 year ago |
|
5
Fate Therapeutics
FATE
$118M
| $1.02 | $9 |
782%
upside
| Buy |
10 May ‘24
1 year ago |
|
6
Immunocore
IMCR
$1.84B
| $36.57 | $67 |
83%
upside
| Hold |
9 May ‘24
1 year ago |
|
7
Moderna
MRNA
$9.88B
| $25.39 | $106 |
317%
upside
| Hold |
3 May ‘24
1 year ago |
|
8
Century Therapeutics
IPSC
$44.8M
| $0.5183 | $24 |
4,531%
upside
| Buy |
15 Mar ‘24
1 year ago |
|
|
BCYC
9
Bicycle Therapeutics
BCYC
$487M
| $7.02 | $60 |
755%
upside
| Buy |
21 Feb ‘24
1 year ago |
|
10
Merus
MRUS
$5.28B
| $69.80 | $45 |
36%
downside
| Buy |
2 Nov ‘23
1 year ago |
|